In Brief: Financial disclosure by clinical investigators
This article was originally published in The Tan Sheet
Executive Summary
Financial disclosure by clinical investigators: Public hearing on FDA's proposed regulation will be held on July 20 at the Wilson Auditorium on the NIH campus beginning at 9 a.m. The hearing will solicit comments on FDA's Sept. 24 proposed reg, which would require sponsors either to certify that investigators do not have financial arrangements that hinge on a study or to describe specific arrangements the company has taken to minimize investigator bias ("The Tan Sheet" Sept. 26, 1994, p. 14). The proposed reg would apply to investigators involved in OTC monograph studies...